Form 8-K - Current report:
SEC Accession No. 0001493152-25-022378
Filing Date
2025-11-13
Accepted
2025-11-13 16:50:42
Documents
16
Period of Report
2025-11-13
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K form8-k.htm   iXBRL 8-K 42952
2 EX-99.1 ex99-1.htm EX-99.1 61562
3 GRAPHIC form8-k_001.jpg GRAPHIC 5935
4 GRAPHIC ex99-1_001.jpg GRAPHIC 43815
  Complete submission text file 0001493152-25-022378.txt   400982

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE bgms-20251113.xsd EX-101.SCH 3749
6 XBRL DEFINITION FILE bgms-20251113_def.xml EX-101.DEF 26585
7 XBRL LABEL FILE bgms-20251113_lab.xml EX-101.LAB 36613
8 XBRL PRESENTATION FILE bgms-20251113_pre.xml EX-101.PRE 25209
18 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 5747
Mailing Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922
Business Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922 908-517-7330
Bio Green Med Solution, Inc. (Filer) CIK: 0001130166 (see all company filings)

EIN.: 911766850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-50626 | Film No.: 251479385
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)